Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes: Influence of different chemical linkages and epitope orientations on biological activity

Vaccine

Volumn 19, Issue 28-29, 2001, Pages 3843-3852

  Zeng, Weiguang ^a   Ghosh, Souravi ^a   Macris, Mary ^a   Pagnon, Joanne ^a   Jackson, David C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chemoselective ligation; Synthetic peptide; Synthetic vaccine

Indexed keywords

EPITOPE; OXIME; SULFIDE; SYNTHETIC PEPTIDE VACCINE; UNCLASSIFIED DRUG; VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CHEMISTRY; CONTROLLED STUDY; DISULFIDE BOND; DRUG ACTIVITY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; LIGATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOICHIOMETRY; VACCINE PRODUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; EPITOPES; FEMALE; FERTILITY; GONADOTROPIN-RELEASING HORMONE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PREGNANCY; T-LYMPHOCYTES; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 0035898952     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00152-9     Document Type: Article

References (32)

1. Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone, and thiazolidine linkages
2. Peptide synthesis using unprotected peptides through orthogonal coupling methods
3. Peptide ligation and semisynthesis
4. Chemical protein synthesis
5. Orthogonal ligation strategies for peptide and protein
6. A synthetic peptide-based polyoxime vaccine construct of high purity and activity
7. The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants
8. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens
9. One-Pot synthesis of antigen-bearing, lysine-based cluster mannosides using two orthogonal chemoselective ligation reactions
10. A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity
11. Facile synthesis of homogeneous artificial proteins
12. A new synthetic functionalized antigen carrier
13. Constructing proteins by dovetailing unprotected synthetic peptides: Backbone-engineered HIV protease
14. Synthesis of peptide Dendrimer
15. Unprotected peptides as building blocks for branched peptides and peptide dendrimers
16. Natural peptides as building blocks for the synthesis of large protein-like molecules with hydrazone and oxime linkages
17. Changes in the ovaries of rats after immunization against luteinizing hormone releasing hormone
18. Effect of active immunization to luteinizing hormone releasing hormone on serum and pituitary gonadotrophins, testes and accessory sex organs in the male rat
19. Antigenic and immunogenic properties of synthetic peptide-based T-cell determinant polymers
20. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines
21. Preparation and properties of totally synthetic immunogens
22. Carrier-priming leads to hapten-specific suppression
23. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines
24. New cyclization reaction at the amino terminus of peptides and proteins
25. Peptides as antigens. Importance of orientation
26. Use of T cell epitopes in raising immune reponse
27. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides
28. The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequences
29. Active immunization against LHRH: I. Effects of conjugation site and dose
30. Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum
31. Serum stability of phophpeptides
32. The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells